Bankrupt biopharmaceutical company Vivus Inc. has agreed to drop some Chapter 11 plan terms that shareholders called a "death trap" for potential equity committee organizers or those stockholders who reject some plan provisions, with wiped-out stockholders now scheduled to battle for their own panel on Friday.